Drug Pipeline

Levothyroxine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
5
Recruiting
3
Phase 3
7
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2/3
2
Phase 2
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07332273 Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity. Obesity Recruiting
Phase 2/3
NCT06345339 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4… Hypothyroidism Recruiting
NCT06731764 Novel Approaches to the Treatment of Hypothyroidism Hypothyroidism Recruiting
Phase 2
NCT05526144 Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans Nonalcoholic Steatohepatitis Recruiting
Not specified
NCT07380854 Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With… Subclinical Hypothyroidism Recruiting
NCT06647602 Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy Differentiated Thyroid Cancer Not Yet Recruiting
NCT07568574 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes Enrolling by Invitation
Sponsors Running Levothyroxine Trials
VA Office of Research and Development (1) AbbVie (1) University Medical Center Groningen (1) UConn Health (1) Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1) Seoul National University Bundang Hospital (1) Enhanced Emirates Limited (1)
Disease Areas
Thyroid Cancer (1) Obesity (1)
Get alerts when Levothyroxine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free